Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of BK Viremia in Kidney Transplant Patients Using the Seraph 100 Microbind® Affinity (Seraph 100) Blood Filter

NCT04984902 is registered in ClinicalTrials.gov with ExThera Medical Europe BV as lead sponsor.

NCT NCT04984902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04984902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of BK Viremia in Kidney Transplant Patients Using the Seraph 100 Microbind® Affinity (Seraph 100) Blood Filter
Lead sponsor
ExThera Medical Europe BV
Phase
Not applicable
Overall status
Withdrawn
Start date
February 1, 2022
Completion date
April 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases, kidney transplant infection, kidney transplant; complications